Current treatment of low grade gliomas

Low grade gliomas affect predominantly young adults, and have a relatively favorable prognosis compared to grade III and grade IV gliomas. The challenge for an optimal management of these patients is to find the balance between an optimal survival and the preservation of neurological function includ...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Bent, Martin J., Snijders, Tom J., Bromberg, Jacoline E. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458190/
https://www.ncbi.nlm.nih.gov/pubmed/23864911
http://dx.doi.org/10.1007/s12254-012-0014-3
_version_ 1782244634480607232
author van den Bent, Martin J.
Snijders, Tom J.
Bromberg, Jacoline E. C.
author_facet van den Bent, Martin J.
Snijders, Tom J.
Bromberg, Jacoline E. C.
author_sort van den Bent, Martin J.
collection PubMed
description Low grade gliomas affect predominantly young adults, and have a relatively favorable prognosis compared to grade III and grade IV gliomas. The challenge for an optimal management of these patients is to find the balance between an optimal survival and the preservation of neurological function including cognition. Because all medical treatments may induce side effects, in young and nearly asymptomatic patients the choices can be difficult. This review summarizes the current strategies: a watch-and-wait policy, surgery, chemotherapy, and radiotherapy.
format Online
Article
Text
id pubmed-3458190
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-34581902013-07-15 Current treatment of low grade gliomas van den Bent, Martin J. Snijders, Tom J. Bromberg, Jacoline E. C. Memo Review Low grade gliomas affect predominantly young adults, and have a relatively favorable prognosis compared to grade III and grade IV gliomas. The challenge for an optimal management of these patients is to find the balance between an optimal survival and the preservation of neurological function including cognition. Because all medical treatments may induce side effects, in young and nearly asymptomatic patients the choices can be difficult. This review summarizes the current strategies: a watch-and-wait policy, surgery, chemotherapy, and radiotherapy. Springer Vienna 2012-06-05 2012 /pmc/articles/PMC3458190/ /pubmed/23864911 http://dx.doi.org/10.1007/s12254-012-0014-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/4.0/Dieser Artikel ist unter den Bedingungen der Creative Commons Attribution Noncommercial Lizenz erlaubt, die alle nicht-kommerziellen Gebrauch, Verbreitung, Vervielfältigung und in beliebiger Form, sofern die Original-Autor (en) und die Quelle genannt werden.
spellingShingle Review
van den Bent, Martin J.
Snijders, Tom J.
Bromberg, Jacoline E. C.
Current treatment of low grade gliomas
title Current treatment of low grade gliomas
title_full Current treatment of low grade gliomas
title_fullStr Current treatment of low grade gliomas
title_full_unstemmed Current treatment of low grade gliomas
title_short Current treatment of low grade gliomas
title_sort current treatment of low grade gliomas
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458190/
https://www.ncbi.nlm.nih.gov/pubmed/23864911
http://dx.doi.org/10.1007/s12254-012-0014-3
work_keys_str_mv AT vandenbentmartinj currenttreatmentoflowgradegliomas
AT snijderstomj currenttreatmentoflowgradegliomas
AT brombergjacolineec currenttreatmentoflowgradegliomas

Ejemplares similares